Pemetrexed Baxter Unia Europejska - polski - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - Środki przeciwnowotworowe - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Injectio Solutionis Ringeri Baxter (8,6 mg + 0,3 mg + 0,32 mg)/ml roztwór do infuzji Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

injectio solutionis ringeri baxter (8,6 mg + 0,3 mg + 0,32 mg)/ml roztwór do infuzji

baxter polska sp. z o.o. - calcii chloridum dihydricum,kalii chloridum,natrii chloridum - roztwór do infuzji - (8,6 mg + 0,3 mg + 0,32 mg)/ml